As lentiviral vector (LVV) programs advance toward larger clinical trials and commercialization, manufacturing platforms and ...
Genezen has opened its new process development and analytical lab for viral vector production. Genezen, a cell and gene therapy contract development and manufacturing organization, has officially ...
BOYNTON BEACH, Fla.--(BUSINESS WIRE)--Estimating Edge, a trusted provider of professional estimating and takeoff software, today announced that the company has been granted U.S. Patent No. 11,321,500 ...
Pharmaceutical Technology spoke with Tania Pereira Chilima, Deputy CTO at Univercells Technologies about their technology and how it can be used in viral vector manufacturing, which is needed for ...
Cell and gene therapies offer hope for previously untreatable diseases, with viral vectors currently favored as the primary gene delivery method. To meet patient needs, reliable and cost-effective ...
Effective process development for viral vector-based medicines is paramount for optimized process efficiency, robustness, scalability, and product quality. Well-designed processes streamline ...
Enhancing Scale-Up, Increasing Quality, and Reducing Costs for AVs, LVVs, AAVs and More The 3rd Viral Vector Process Development and Manufacturing Summit returns to Boston, uniting industry leaders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results